None
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects of both sexes aged 18 years or older.
Exclusion criteria
Exclusion criteria: 1)Subjects with serious disorders on malignant tumors, respiratory disease, hepatic, kidney, cardiac, lung, digestive organs, blood, endocrine system and metabolic system, or related severe past medical histories 2)Subjects with medication allergy, food allergy, or serious history of these 3)Subjects who are pregnant, under lactation or expecting to be pregnant during this study 4)Subjects with suffering from autoimmune diseases 5)Subjects who plan to use drugs that may affect immune response and intestinal flora (antiallergic agents, anti-inflammatory agents, antibiotics, drugs for digestive system treatment, diabetes drugs) from the time consent is obtained to the end of the study. 6)Subjects who plan to be vaccinated against influenza, COVID-19, or other infectious diseases from the time consent is obtained to the end of the study. 7)Any candidates considered to be inappropriate for this study by the principal investigator based on their background, physical examination, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of immunity parameters, Intestinal flora, Survey of background information on the subject | — |
Countries
Japan
Contacts
MORINAGA MILK INDUSTRY CO.,LTD. Innovative Research Institute R&D Division